GlassScriptPhysician profile
Atiya Gopalani
NPI 1407894124
$939.92
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $428 · 2021: $238 · 2022: $19.34.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $271.29 | 2019-2022 | |
| Therapeuticsmd, INC. | $185.28 | 2019-2021 | |
| Pfizer INC. | $159.01 | 2019-2021 | |
| Avion Pharmaceuticals | $76.50 | 2019-2021 | |
| Lupin INC. | $57.85 | 2019-2020 | |
| Tactile Systems Technology INC | $57.14 | 2019 | |
| Hologic Sales and Service, LLC | $49.51 | 2020 | |
| Allergan, INC. | $31.37 | 2019 | |
| Millicent US INC | $26.62 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $13.55 | 2019 | |
| Evofem Biosciences, INC. | $11.80 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atiya Gopalani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.